Medipal Holdings Corporation operates in the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Medipal Holdings with three other
companies in this sector in Japan:
Alfresa Holdings Corporation
sales of 2.55 trillion Japanese Yen [US$23.09 billion]
of which 88%
was Wholesale Business of Pharmaceuticals fo),
Toho Holdings Company Limited
(1.23 trillion Japanese Yen [US$11.14 billion]
of which 92%
was Pharmaceutical Wholesale Business), and
Suzuken Co., Ltd.
(2.13 trillion Japanese Yen [US$19.25 billion]
of which 93%
was Pharmaceutical Wholesale Business).
Medipal Holdings reported sales of ¥3.06 trillion (US$27.73 billion)
March of 2017.
a very small
increase of 1.2%
versus 2016, when the company's sales were ¥3.03 trillion.
Sales of Related Business saw an increase
that was more than double the company's growth rate: sales were up
26.7% in 2017, from
¥47.18 billion to ¥59.76 billion.
Medipal Holdings also saw significant increases in sales in
Daily Necessities, Cosmetics, Pharmaceut (up 7.2% to ¥921.22 billion)
Not all segments of Medipal Holdings experienced an increase in sales in 2017:
sales of Pharmaceuticals and Food Precessing Whol fell 1.8% to ¥2.08 trillion.